JAYPIRCA (pirtobrutinib) Patient Assistance Program
Don’t let the high cost of brand specialty leukemia/lymphoma therapy stand between you and the treatment you need. We help eligible patients access Jaypirca (pirtobrutinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Jaypirca (pirtobrutinib) is FDA-approved for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two prior lines of therapy including a BTK inhibitor, and for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy including a BTK inhibitor and a BCL-2 inhibitor.
- Without assistance, the retail cost commonly runs approximately $20,000–$24,000 per 30-day supply at the standard 200 mg daily dose.
- Through AffordMyPrescriptions, qualifying patients can access Jaypirca for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Jaypirca available in the U.S. as of 2026.
What is Jaypirca Prescription Assistance Program?
The Jaypirca Prescription Assistance Program is a manufacturer-sponsored initiative that provides Jaypirca at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for patients with relapsed/refractory MCL or CLL/SLL who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-treatment documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork
Pharmacy Price Comparison
- Without assistance, Jaypirca costs roughly $20,000–$24,000 per 30-day supply at retail pharmacies. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$23,500.00 | Save ~$23,430/mo |
| CVS Pharmacy | ~$24,000.00 | Save ~$23,930/mo |
| Walmart | ~$21,500.00 | Save ~$21,430/mo |
| Costco | ~$20,800.00 | Save ~$20,730/mo |
| Specialty Pharmacy | ~$21,000.00 | Save ~$20,930/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Jaypirca Prescription Program?
The Patient Assistance Program is free to apply for and provides Jaypirca at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-treatment documentation (BTK inhibitor and BCL-2 inhibitor history for CLL/SLL), specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Jaypirca:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $20,000–$24,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Jaypirca assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Jaypirca Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Jaypirca:
Jaypirca (pirtobrutinib) is an oral, targeted oncology medicine in the non-covalent (reversible) BTK inhibitor class. It is approved for adults with relapsed or refractory mantle cell lymphoma after at least two prior lines of therapy (including a covalent BTK inhibitor like ibrutinib, acalabrutinib, or zanubrutinib), and for adults with relapsed or refractory CLL/SLL after a BTK inhibitor and a BCL-2 inhibitor.
How It Works:
Jaypirca is a non-covalent BTK inhibitor designed to treat B-cell cancers like mantle cell lymphoma that have become resistant to older treatments. While first-generation inhibitors often fail due to specific mutations, Jaypirca binds to the BTK enzyme in a reversible way that remains effective against those resistance mutations. This allows the medication to restore control over the cancer signals even after other therapies have stopped working.
Form and Use:
The recommended dose is 200 mg taken orally once every day, and it can be taken with or without food. It is important to swallow the tablets whole rather than crushing or breaking them. Treatment usually continues as long as the patient is showing a response, though oncology teams may modify the dosage to manage side effects such as infections or changes in blood counts.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Jaypirca available in the U.S. due to active patent and exclusivity protections. While other treatments like BCL-2 inhibitors, CAR-T therapy, or chemotherapy exist for these types of leukemia and lymphoma, Jaypirca occupies a specific role for patients who have progressed on previous inhibitors. Any decision to explore these alternative treatment paths belongs with your oncology team.
Warnings:
The FDA label includes warnings for potential risks such as serious infections, hemorrhage, and low blood counts (cytopenias). Patients should also be monitored for heart rhythm issues like atrial fibrillation, as well as the development of second primary malignancies. Standard care during treatment includes regular blood-count monitoring and ongoing assessments by your medical team for cardiovascular and infection risks.
FAQ (Frequently Asked Questions)
How Much Does Jaypirca Cost Without Insurance?
The retail price commonly runs $20,000–$24,000 per 30-day supply at the standard 200 mg daily dose. Coupon discounts at major pharmacies exist but are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Jaypirca at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Jaypirca Different From Other BTK Inhibitors?
Jaypirca is a non-covalent (reversible) BTK inhibitor, while older BTK inhibitors (ibrutinib, acalabrutinib, zanubrutinib) bind covalently. Jaypirca was specifically designed to remain effective against resistance mutations that can develop on covalent BTK inhibitors, which is why it is approved specifically for patients whose cancer has progressed on prior BTK-directed therapy.
How Is Jaypirca Taken?
Jaypirca is taken at 200 mg by mouth once daily, with or without food. Tablets should be swallowed whole. Take it at roughly the same time each day. Treatment is continued until disease progression or unacceptable toxicity.
Can I Get Jaypirca Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Jaypirca Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
Are There Other Treatment Options For Relapsed MCL Or CLL?
Yes. Other options include BCL-2 inhibitors (venetoclax), CAR-T cell therapy, combination chemotherapy regimens, and re-treatment with different covalent BTK inhibitors. Whether any of these is a clinical fit depends on your prior treatments, performance status, and other factors. We mention this directly because if a different therapy on a more accessible assistance pathway would work, that may be a better path.
How Long Does It Take To Get Approved?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent foundations such as the PAN Foundation, HealthWell Foundation, or the Leukemia & Lymphoma Society Co-Pay Assistance Program, the Lymphoma Research Foundation, the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different therapy would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Jaypirca, our team may be able to help you access assistance programs designed to make brand specialty leukemia/lymphoma therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.